SMTL ID : 7uw6.1

The co-crystal structure of low molecular weight protein tyrosine phosphatase (LMW-PTP) with a small molecule inhibitor SPAA-2

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.50 Å

Oligo State

monomer

Ligands

1 x OIF: 2-[(1,3-benzothiazol-2-yl)amino]-2-oxoethane-1-sulfonic acid(Non-covalent)

OIF.1: 11 residues within 4Å: Chain A: C.32, L.33, G.34, N.35, I.36, C.37, R.38, Y.69, D.149, Y.151, Y.152 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:Y.69, A:Y.152 Hydrogen bonds: A:L.33, A:G.34, A:N.35, A:I.36, A:C.37, A:R.38, A:D.149 Salt bridges: A:R.38 pi-Stacking: A:Y.69

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

He, R. et al., Structure-Based Design of Active-Site-Directed, Highly Potent, Selective, and Orally Bioavailable Low-Molecular-Weight Protein Tyrosine Phosphatase Inhibitors. J.Med.Chem. (2022)

Release Date

2022-10-19

Peptides

Low molecular weight phosphotyrosine protein phosphatase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Low molecular weight phosphotyrosine protein phosphatase